1. Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish
    Hui Luo et al, 2019, Atherosclerosis CrossRef
  2. Atherosclerosis and Autoimmunity
    C. Perricone et al, 2017, The Heart in Systemic Autoimmune Diseases CrossRef
  3. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment
    Sanne J. C. M. Frambach et al, 2020, Pharmacological Reviews CrossRef
  4. Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264.7 cells by promoting ABCA1 mediated cholesterol efflux
    Cheng Zhang et al, 2023, Frontiers in Pharmacology CrossRef
  5. Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus
    Xiaoli Wu, 2019, Experimental and Therapeutic Medicine CrossRef
  6. Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease
    Anca Ungurianu et al, 2017, Molecular Medicine Reports CrossRef
  7. Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective
    Ali Ahmadi et al, 2022, Drug Discovery Today CrossRef
  8. Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases
    Waleska Dornas et al, 2024, Nutrition, Metabolism and Cardiovascular Diseases CrossRef
  9. Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease
    Jayne Louise Wilson et al, 2019, Frontiers in Immunology CrossRef
  10. Simultaneous Rosiglitazone Release and Low-Density Lipoprotein Removal by Chondroitin Sodium Sulfate/Cyclodextrin/Poly(acrylic acid) Composite Adsorbents for Atherosclerosis Therapy
    Yujie Xiao et al, 2024, Biomacromolecules CrossRef
  11. Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression
    Michael J. Haas et al, 2022, Drugs CrossRef
  12. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation
    Yasaman Shokri et al, 2020, Diabetes Research and Clinical Practice CrossRef